Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas

Ilana Cass, Andrew J. Li, Carolyn D. Runowicz, Abbie L. Fields, Gary L. Goldberg, Ronald S. Leuchter, Leo D. Lagasse, Beth Y. Karlan

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Purpose. There is controversy regarding the pattern of lymphatic spread in unilateral stage I invasive ovarian carcinomas. The purpose of this study is to describe the incidence and distribution of lymph node (LN) metastases in ovarian carcinomas clinically confined to one ovary. Methods. Ninety-six patients with disease visibly confined to one ovary were identified. Pathology reports were reviewed to identify metastatic LN involvement, number of involved nodes, and their locations. Patients with gross disease in the pelvis or abdomen or those who had grossly positive LNs removed for debulking were excluded from this review. Results. Fourteen of ninety-six patients (15%) had microscopically positive LNs on pathologic review. All of these 14 patients had grade 3 tumors. Grade 3 tumors were more commonly seen in LN-positive versus LN-negative patients (P < 0.001). Pelvic nodes were positive in 7 patients (50%), paraaortic nodes in 5 patients (36%), and both in 2 patients (14%). Forty-two patients had LN sampling only on the side ipsilateral to the neoplastic ovary, 4 of whom (10%) had LN metastases. Fifty-four patients had bilateral sampling performed, 10 of whom (19%) had LN metastases. Of these 10 patients, isolated ipsilateral LN metastases were seen in 5 (50%) cases. Isolated contralateral LN metastases were seen in 3 (30%) cases, and bilateral metastases were seen in 2 (20%). Conclusions. In this cohort of patients with clinical stage I ovarian carcinoma with disease limited to one ovary, bilateral LN sampling increased the identification of nodal metastases. Ipsilateral sampling may result in the understaging of patients. Bilateral pelvic and paraaortic LN sampling is recommended to accurately stage ovarian carcinoma.

Original languageEnglish (US)
Pages (from-to)56-61
Number of pages6
JournalGynecologic Oncology
Volume80
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Lymph Nodes
Neoplasm Metastasis
Carcinoma
Ovary
Pelvis
Abdomen
Neoplasms
Pathology
Incidence

Keywords

  • Epithelial ovarian carcinoma
  • Lymph node metastasis

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Cass, I., Li, A. J., Runowicz, C. D., Fields, A. L., Goldberg, G. L., Leuchter, R. S., ... Karlan, B. Y. (2001). Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecologic Oncology, 80(1), 56-61. https://doi.org/10.1006/gyno.2000.6027

Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. / Cass, Ilana; Li, Andrew J.; Runowicz, Carolyn D.; Fields, Abbie L.; Goldberg, Gary L.; Leuchter, Ronald S.; Lagasse, Leo D.; Karlan, Beth Y.

In: Gynecologic Oncology, Vol. 80, No. 1, 2001, p. 56-61.

Research output: Contribution to journalArticle

Cass, I, Li, AJ, Runowicz, CD, Fields, AL, Goldberg, GL, Leuchter, RS, Lagasse, LD & Karlan, BY 2001, 'Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas', Gynecologic Oncology, vol. 80, no. 1, pp. 56-61. https://doi.org/10.1006/gyno.2000.6027
Cass, Ilana ; Li, Andrew J. ; Runowicz, Carolyn D. ; Fields, Abbie L. ; Goldberg, Gary L. ; Leuchter, Ronald S. ; Lagasse, Leo D. ; Karlan, Beth Y. / Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. In: Gynecologic Oncology. 2001 ; Vol. 80, No. 1. pp. 56-61.
@article{5e0eafc895e741e88994f049f99db7d6,
title = "Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas",
abstract = "Purpose. There is controversy regarding the pattern of lymphatic spread in unilateral stage I invasive ovarian carcinomas. The purpose of this study is to describe the incidence and distribution of lymph node (LN) metastases in ovarian carcinomas clinically confined to one ovary. Methods. Ninety-six patients with disease visibly confined to one ovary were identified. Pathology reports were reviewed to identify metastatic LN involvement, number of involved nodes, and their locations. Patients with gross disease in the pelvis or abdomen or those who had grossly positive LNs removed for debulking were excluded from this review. Results. Fourteen of ninety-six patients (15{\%}) had microscopically positive LNs on pathologic review. All of these 14 patients had grade 3 tumors. Grade 3 tumors were more commonly seen in LN-positive versus LN-negative patients (P < 0.001). Pelvic nodes were positive in 7 patients (50{\%}), paraaortic nodes in 5 patients (36{\%}), and both in 2 patients (14{\%}). Forty-two patients had LN sampling only on the side ipsilateral to the neoplastic ovary, 4 of whom (10{\%}) had LN metastases. Fifty-four patients had bilateral sampling performed, 10 of whom (19{\%}) had LN metastases. Of these 10 patients, isolated ipsilateral LN metastases were seen in 5 (50{\%}) cases. Isolated contralateral LN metastases were seen in 3 (30{\%}) cases, and bilateral metastases were seen in 2 (20{\%}). Conclusions. In this cohort of patients with clinical stage I ovarian carcinoma with disease limited to one ovary, bilateral LN sampling increased the identification of nodal metastases. Ipsilateral sampling may result in the understaging of patients. Bilateral pelvic and paraaortic LN sampling is recommended to accurately stage ovarian carcinoma.",
keywords = "Epithelial ovarian carcinoma, Lymph node metastasis",
author = "Ilana Cass and Li, {Andrew J.} and Runowicz, {Carolyn D.} and Fields, {Abbie L.} and Goldberg, {Gary L.} and Leuchter, {Ronald S.} and Lagasse, {Leo D.} and Karlan, {Beth Y.}",
year = "2001",
doi = "10.1006/gyno.2000.6027",
language = "English (US)",
volume = "80",
pages = "56--61",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas

AU - Cass, Ilana

AU - Li, Andrew J.

AU - Runowicz, Carolyn D.

AU - Fields, Abbie L.

AU - Goldberg, Gary L.

AU - Leuchter, Ronald S.

AU - Lagasse, Leo D.

AU - Karlan, Beth Y.

PY - 2001

Y1 - 2001

N2 - Purpose. There is controversy regarding the pattern of lymphatic spread in unilateral stage I invasive ovarian carcinomas. The purpose of this study is to describe the incidence and distribution of lymph node (LN) metastases in ovarian carcinomas clinically confined to one ovary. Methods. Ninety-six patients with disease visibly confined to one ovary were identified. Pathology reports were reviewed to identify metastatic LN involvement, number of involved nodes, and their locations. Patients with gross disease in the pelvis or abdomen or those who had grossly positive LNs removed for debulking were excluded from this review. Results. Fourteen of ninety-six patients (15%) had microscopically positive LNs on pathologic review. All of these 14 patients had grade 3 tumors. Grade 3 tumors were more commonly seen in LN-positive versus LN-negative patients (P < 0.001). Pelvic nodes were positive in 7 patients (50%), paraaortic nodes in 5 patients (36%), and both in 2 patients (14%). Forty-two patients had LN sampling only on the side ipsilateral to the neoplastic ovary, 4 of whom (10%) had LN metastases. Fifty-four patients had bilateral sampling performed, 10 of whom (19%) had LN metastases. Of these 10 patients, isolated ipsilateral LN metastases were seen in 5 (50%) cases. Isolated contralateral LN metastases were seen in 3 (30%) cases, and bilateral metastases were seen in 2 (20%). Conclusions. In this cohort of patients with clinical stage I ovarian carcinoma with disease limited to one ovary, bilateral LN sampling increased the identification of nodal metastases. Ipsilateral sampling may result in the understaging of patients. Bilateral pelvic and paraaortic LN sampling is recommended to accurately stage ovarian carcinoma.

AB - Purpose. There is controversy regarding the pattern of lymphatic spread in unilateral stage I invasive ovarian carcinomas. The purpose of this study is to describe the incidence and distribution of lymph node (LN) metastases in ovarian carcinomas clinically confined to one ovary. Methods. Ninety-six patients with disease visibly confined to one ovary were identified. Pathology reports were reviewed to identify metastatic LN involvement, number of involved nodes, and their locations. Patients with gross disease in the pelvis or abdomen or those who had grossly positive LNs removed for debulking were excluded from this review. Results. Fourteen of ninety-six patients (15%) had microscopically positive LNs on pathologic review. All of these 14 patients had grade 3 tumors. Grade 3 tumors were more commonly seen in LN-positive versus LN-negative patients (P < 0.001). Pelvic nodes were positive in 7 patients (50%), paraaortic nodes in 5 patients (36%), and both in 2 patients (14%). Forty-two patients had LN sampling only on the side ipsilateral to the neoplastic ovary, 4 of whom (10%) had LN metastases. Fifty-four patients had bilateral sampling performed, 10 of whom (19%) had LN metastases. Of these 10 patients, isolated ipsilateral LN metastases were seen in 5 (50%) cases. Isolated contralateral LN metastases were seen in 3 (30%) cases, and bilateral metastases were seen in 2 (20%). Conclusions. In this cohort of patients with clinical stage I ovarian carcinoma with disease limited to one ovary, bilateral LN sampling increased the identification of nodal metastases. Ipsilateral sampling may result in the understaging of patients. Bilateral pelvic and paraaortic LN sampling is recommended to accurately stage ovarian carcinoma.

KW - Epithelial ovarian carcinoma

KW - Lymph node metastasis

UR - http://www.scopus.com/inward/record.url?scp=0035166671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035166671&partnerID=8YFLogxK

U2 - 10.1006/gyno.2000.6027

DO - 10.1006/gyno.2000.6027

M3 - Article

C2 - 11136570

AN - SCOPUS:0035166671

VL - 80

SP - 56

EP - 61

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -